(4R)-4-amino-5-oxohexanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (4R)-4-amino-5-oxohexanoic acid
• 化学式: C₆H₁₁NO₃
• 分子量: 145.16
• InChiKey: BEQNQQMUNXSRBI-RXMQYKEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.4
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  80.4
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• [EN] N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO<br/>[FR] N4-HYDROXYCYTIDINE ET SES DÉRIVÉS ET UTILISATIONS ANTIVIRALES ASSOCIÉES
  申请人：UNIV EMORY

  公开号：WO2021159044A1

  公开（公告）日：2021-08-12

  This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of human coronavirus 2019-nCoV.

  这项披露涉及某些N4-羟基胞苷衍生物、药物组合物以及相关方法。在某些实施方式中，该披露涉及治疗或预防人类冠状病毒2019-nCoV。
• INHIBITORS OF CELLULAR NECROSIS AND RELATED METHODS
  申请人：President and Fellows of Harvard College

  公开号：US20160168128A1

  公开（公告）日：2016-06-16

  A compound having the following structure (I): or a pharmaceutically acceptable salt, prodrug, stereoisomer or tautomer thereof, is provided. Related compounds, methods for preparation of the same and uses of the compounds for treatment of various indications, including treatment of necrotic cell diseases and/or inflammation, are also provided.

  提供具有以下结构（I）的化合物或其药学上可接受的盐、前药、立体异构体或互变异构体。还提供相关化合物、其制备方法以及用于治疗各种症状，包括治疗坏死细胞疾病和/或炎症的化合物的用途。
• N4-hydroxycytidine and derivatives and anti-viral uses related thereto
  申请人：EMORY UNIVERSITY

  公开号：US11331331B2

  公开（公告）日：2022-05-17

  This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

  本公开涉及某些 N4-羟基胞苷衍生物、药物组合物及其相关方法。在某些实施方案中，本公开涉及用公开的化合物治疗或预防病毒感染，如东方、西方和委内瑞拉马脑炎（分别为EEE、WEE和VEE）、基孔肯雅热（CHIK）、埃博拉病毒、流感、RSV和寨卡病毒感染。
• N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
  申请人：EMORY UNIVERSITY

  公开号：US20200276219A1

  公开（公告）日：2020-09-03

  This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.
• 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
  申请人：EMORY UNIVERSITY

  公开号：US20210308168A1

  公开（公告）日：2021-10-07

  Disclosed are halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections. Such viral infections can include tongaviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infections.